Trading Signals: RARE Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Oct. 27, 2023)(Ultragenyx Pharmaceutical Inc)
| Market is closed on Wed. Nov. 29, 2023 | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 0% (three month average) | | RSI | | | Latest Price | $(0%) | | Stocks Behave Similarly | Similar Stock List | | Market Behavior | Normal for large cap. Broad based rally for small cap. | | Correlated ETFs | Broad market will support RARE advance at 0% a week (0% probability)
(0%) (0%) (0%) (0%) (0%) | | Factors Impacting RARE price | RARE will advance at least -0% in a week (0% probabilities).
(0%) (0%) (0%) (0%) (0%) | | | | | | | | Relative Volatility | | | | | | Market Trend Strength | 0% (StdDev 0%) | | Hourly BBV | 0 () | | Intraday Trend | NAN% | | | | | |
|
Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development and commercialization of novel products for the treatment of serious rare and ultra-rare genetic diseases. Its product includes Mepsevii and Crysvita. Mepsevii is an intravenous, which is used for the treatment of Mucopolysaccharidosis VII. Crysvita is an antibody administered via subcutaneous injection used for the treatment of XLH. The company was founded by Emil D. Kakkis on April 22, 2010 and is headquartered in Novato, CA. |